Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway
Authors
Keywords
Oral squamous cell carcinoma, Lupeol, EGFR, COX-2
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 417, Issue 1-2, Pages 97-110
Publisher
Springer Nature
Online
2016-05-22
DOI
10.1007/s11010-016-2717-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting clinical response to anticancer drugs using an ex vivo platform that captures tumour heterogeneity
- (2015) Biswanath Majumder et al. Nature Communications
- Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention
- (2014) Samriddhi Shukla et al. CANCER LETTERS
- Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals
- (2014) Onat Kadioglu et al. Targeted Oncology
- Phytochemicals: A Multitargeted Approach to Gynecologic Cancer Therapy
- (2014) Lee Farrand et al. Biomed Research International
- Architecture and Membrane Interactions of the EGF Receptor
- (2013) Anton Arkhipov et al. CELL
- Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness
- (2013) Claudia Bocca et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- MMP1, MMP9, and COX2 Expressions in Promonocytes Are Induced by Breast Cancer Cells and Correlate with Collagen Degradation, Transformation-Like Morphological Changes in MCF-10A Acini, and Tumor Aggressiveness
- (2013) G. K. Chimal-Ramírez et al. Biomed Research International
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation
- (2010) Terence Kin Wah Lee et al. HEPATOLOGY
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
- (2009) A. Greenhough et al. CARCINOGENESIS
- Anti-oxidative and anti-inflammatory activities of some isolated constituents from the stem bark of Allanblackia monticola Staner L.C (Guttiferae)
- (2009) E. L. Nguemfo et al. INFLAMMOPHARMACOLOGY
- Recent Advances in Head and Neck Cancer
- (2008) Robert I. Haddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of HB-EGF and amphiregulin as targets for human cancer therapy
- (2007) Fusanori Yotsumoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now